Cefepime Hydrochloride 1g Intravenous Powder for Injection
This is a sterile lyophilized powder containing cefepime hydrochloride (1 gram per vial) mixed with L-arginine, intended for reconstitution and intravenous administration to treat bacterial infections. It falls under HTS 3004.20.00.71 as a medicament containing cefepime or its salts, put up in measured doses for therapeutic use against gram-negative bacteria. The product is unmixed antibiotic in a single-dose vial suitable for hospital retail packing.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If not put up in measured doses or retail packing
Bulk cefepime powder without individual dosing or retail forms classifies under unmixed medicaments in Chapter 30 for therapeutic uses.
If imported as chemical intermediate without therapeutic labeling
Pure cefepime salts as organic chemicals fall under Chapter 29 if not presented as finished medicaments for prophylactic/therapeutic use.
If containing other antibiotics like penicillins in mixtures
Mixed antibiotic products not specifically cefepime-based shift to other antibiotic subheadings based on principal ingredient.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Obtain FDA approval and NDC numbering prior to import, as cefepime is a prescription antibiotic requiring strict regulatory compliance
• Provide certificates of analysis (COA) confirming cefepime salt purity and sterility to avoid CBP holds at entry
• Ensure proper cold chain documentation if required during transit to maintain efficacy of the lyophilized powder
Related Products under HTS 3004.20.00.71
Cefepime 2g Single-Dose Vial for IV Infusion
A 2-gram vial of cefepime hydrochloride powder for reconstitution into solution, used intravenously for severe infections like pneumonia or sepsis. Classified under HTS 3004.20.00.71 due to its specific cefepime salt content in measured doses for retail sale to healthcare providers. It consists of unmixed antibiotic product in sterile packaging.
Maxipime Cefepime 1g Injection Retail Pack
Branded Maxipime cefepime hydrochloride 1g powder in a retail-ready carton with diluent syringe for hospital use against resistant infections. It qualifies for HTS 3004.20.00.71 as a mixed/unmixed cefepime salt product in measured doses for therapeutic prophylactic uses. Packaging is designed for direct retail sale.
Cefepime 1g Pre-Filled Syringe for Injection
Ready-to-use cefepime hydrochloride 1g in pre-filled syringe for direct therapeutic injection, treating intra-abdominal infections. HTS 3004.20.00.71 applies to this measured-dose cefepime salt product for retail medical use. Form is unmixed antibiotic solution.
Cefepime Hydrochloride Pediatric 250mg Vial
Low-dose 250mg cefepime HCl powder vial for pediatric IV use in neonatal sepsis treatment. Falls under HTS 3004.20.00.71 as measured-dose cefepime salt for prophylactic/therapeutic retail sale. Unmixed product in sterile single-use packaging.
Cefepime Combination 1g + Sulbactam Vial
Cefepime HCl 1g with sulbactam (beta-lactamase inhibitor) in single vial for enhanced broad-spectrum therapy. Still under HTS 3004.20.00.71 if cefepime principal, as mixed antibiotic product in measured doses for retail. Therapeutic for resistant strains.
Cefepime 500mg Oral Suspension Reconstitutable Powder
Reconstitutable powder for oral suspension containing cefepime salt 500mg per dose for outpatient infection treatment. HTS 3004.20.00.71 covers this measured-dose cefepime product put up for retail therapeutic use. Unmixed until reconstitution.